Eikon Therapeutics, Inc. · NASDAQ:EIKN
Abu Dhabi Investment Authority's stake in Eikon Therapeutics, Inc. fell to 2.10% (Schedule 13G/A)
Event Sep 30, 2026 · Filed Oct 2, 2026
Abu Dhabi Investment Authority's stake in Eikon Therapeutics, Inc. fell to 2.10%, 1,147,138 shares, as a passive investor on Sep 30, 2026. Filed Oct 2, 2026 (Schedule 13G/A).
- Stake
- 2.10%
- Shares
- 1,147,138
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Abu Dhabi Investment Authority | 2.10% | 1,147,138 |
| Platinum Falcon B 2018 RSC Limited | 2.10% | 1,147,138 |
Source
Related
- Eikon Therapeutics, Inc.
- Abu Dhabi Investment Authority
- Eikon Therapeutics, Inc. shareholders
- Schedule 13G · Abu Dhabi Investment Authority · Feb 18, 2026
- Schedule 13G/A · FMR LLC · Oct 7, 2026
- Form 4 · Kutzkey Tim · Sep 8, 2026
- Schedule 13G/A · FMR LLC · Aug 6, 2026
- Schedule 13G · Innovation Endeavors III LP · May 15, 2026
- Schedule 13G · Perlmutter Roger M · May 13, 2026